How do you determine if generic vs brand formulation of a DMT is the probable cause of worsening multiple sclerosis disease activity?

I based this on timing of switch to generic formulations, and duration of stability on brand formulation. For example, if a patient has been on brand DMT with stability for 5 years, then recently changed to generic with disease activity within the first year, I would consider that the generic is the...